Aetiology and Management
暂无分享,去创建一个
[1] A. Neugut,et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Debra L Barton,et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial , 2000, The Lancet.
[3] P. Ganz,et al. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. , 2000, Journal of the National Cancer Institute.
[4] G. Lyman,et al. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. , 2000, Journal of pain and symptom management.
[5] P. Flynn,et al. Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study , 2000, Annals of Internal Medicine.
[6] J. Lenihan,et al. Initial 17β‐Estradiol Dose for Treating Vasomotor Symptoms , 2000, Obstetrics and gynecology.
[7] L. Signorello,et al. Factors associated with early menopause. , 2000, Maturitas.
[8] P. Novotny,et al. Tamoxifen-induced hot flashes. , 2000, Clinical breast cancer.
[9] A. Riva,et al. Clinical Effects of a Standardized Soy Extract in Postmenopausal Women: A Pilot Study , 2000, Menopause.
[10] P. Novotny,et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] R. Hoover,et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000, JAMA.
[12] M. Hammar,et al. Concentrations of Calcitonin Gene‐Related Peptide and Neuropeptide Y in Plasma Increase During Flushes in Postmenopausal Women , 2000, Menopause.
[13] R. Mckeown,et al. Overview of women's decision making regarding elective hysterectomy, oophorectomy, and hormone replacement therapy. , 2000, Journal of women's health & gender-based medicine.
[14] J. Hanfelt,et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] M. Andrykowski,et al. Menopausal symptoms in breast cancer survivors. , 1999, Oncology nursing forum.
[16] R. Tummala,et al. The risk of premature menopause induced by chemotherapy for early breast cancer. , 1999, Journal of women's health & gender-based medicine.
[17] D. Lauver,et al. Explaining women's intentions and use of hormones with menopause. , 1999, Research in nursing & health.
[18] R. Gambrell,et al. Estrogen replacement therapy in women with previous breast cancer. , 1999, American journal of obstetrics and gynecology.
[19] J. Pepping. Black cohosh: Cimicifuga racemosa. , 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[20] P. Berghammer,et al. Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women , 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[21] M. Gelfand. Role of androgens in surgical menopause. , 1999, American journal of obstetrics and gynecology.
[22] G. Bachmann. Vasomotor flushes in menopausal women. , 1999, American journal of obstetrics and gynecology.
[23] R. Moore. Livial: a review of clinical studies. , 1999, British journal of obstetrics and gynaecology.
[24] D. Taylor,et al. Symptom experience of Filipino American midlife women. , 1999, Menopause.
[25] F. Figueras,et al. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. , 1999, Menopause.
[26] M. Moen,et al. Why menopausal women do not want to take hormone replacement therapy. , 1999, Menopause.
[27] W. Holzgreve,et al. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. , 1999, Menopause.
[28] Susan R. Johnson,et al. Symptom Relief and Side Effects of Postmenopausal Hormones: Results From the Postmenopausal Estrogen/Progestin Interventions Trial , 1998, Obstetrics and gynecology.
[29] M. Hammar,et al. Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide. , 1998, Maturitas.
[30] R. Di Micco,et al. Tibolone: a review. , 1998, Maturitas.
[31] J. Sloan,et al. Definitions of hot flashes in breast cancer survivors. , 1998, Journal of pain and symptom management.
[32] G. Heller,et al. Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group. , 1998, Climacteric : the journal of the International Menopause Society.
[33] S. Christau,et al. A double‐blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms , 1998, British journal of obstetrics and gynaecology.
[34] R. Freedman. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. , 1998, Fertility and sterility.
[35] E. Perez,et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] S Lieberman,et al. A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. , 1998, Journal of women's health.
[37] J. Sloan,et al. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes , 1998, Cancer.
[38] H. Scher,et al. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer , 1998, Psycho-oncology.
[39] P. Novotny,et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] Barbara B. Hodgson,et al. Saunders nursing drug handbook , 1998 .
[41] E. Beller,et al. A cohort study of hormone replacement therapy given to women previously treated for breast cancer. , 1998, Climacteric : the journal of the International Menopause Society.
[42] E. Liske. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. , 1998, Advances in therapy.
[43] K. Wijma,et al. Treatment of menopausal symptoms with applied relaxation: a pilot study. , 1997, Journal of behavior therapy and experimental psychiatry.
[44] G. Brengelmann,et al. Control of skin blood flow in the neutral zone of human body temperature regulation. , 1996, Journal of applied physiology.
[45] M. Dören,et al. The impact of different HRT regimens on compliance. , 1996, International journal of fertility and menopausal studies.
[46] L. Zanotti,et al. The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints. , 1994, European journal of obstetrics, gynecology, and reproductive biology.
[47] B. Oddens. The climacteric cross-culturally: the International Health Foundation South-east Asia study. , 1994, Maturitas.
[48] J. O'fallon,et al. Megestrol acetate for the prevention of hot flashes. , 1994, The New England journal of medicine.
[49] J. O'fallon,et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] K. McPherson,et al. Measuring the impact of menopausal symptoms on quality of life. , 1993, BMJ.
[51] R. Freedman,et al. Behavioral treatment of menopausal hot flushes: Evaluation by ambulatory monitoring , 1992 .
[52] C. Webber,et al. Psychosocial adjustment in post-menopausal women. , 1992, The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres.
[53] P. Vercellini,et al. Veralipride for hot flushes during gonadotropin-releasing hormone agonist treatment. , 1992, Gynecologic and obstetric investigation.
[54] F. Pannuti,et al. High-dose medroxyprogesterone acetate versus oophorectomy as first-line therapy of advanced breast cancer in premenopausal patients. , 1991, Oncology.
[55] A. Køster. Hormone replacement therapy: use patterns in 51-year-old Danish women. , 1990, Maturitas.
[56] Fredi Kronenberg,et al. Hot Flashes: Epidemiology and Physiologya , 1990, Annals of the New York Academy of Sciences.
[57] S. Levine-Silverman. The menopausal hot flash: a procrustean bed of research. , 1989, Journal of advanced nursing.
[58] P. Fioretti,et al. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women , 1988, Obstetrics and gynecology.
[59] K. Verbeke,et al. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women. , 1988, Maturitas.
[60] G. Tajchner,et al. Veralipride: alternative antidopaminergic treatment for menopausal symptoms. , 1988, American journal of obstetrics and gynecology.
[61] J. Ubachs,et al. Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study. , 1987, Maturitas.
[62] M. Mauloni,et al. Use of Org OD 14 for the treatment of climacteric complaints. , 1987, Maturitas.
[63] F. Petraglia,et al. Benefits and risks of different hormonal replacement therapies in post-menopausal women. , 1986, Maturitas.
[64] L. Brown,et al. A double‐blind trial with clonidine and a placebo to treat hot flushes , 1986, The Medical journal of Australia.
[65] R. Freedman,et al. Behavioral treatment of menopausal hot flashes: evaluation by objective methods. , 1984, Journal of consulting and clinical psychology.
[66] M. Hammond,et al. A double blind study to evaluate the effect of methyldopa on menopausal vasomotor flushes. , 1984, The Journal of clinical endocrinology and metabolism.
[67] R. Lobo,et al. Depo‐Medroxyprogesterone Acetate Compared With Conjugated Estrogens for the Treatment of Postmenopausal Women , 1984, Obstetrics and gynecology.
[68] R. P. Bourguignon,et al. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes. , 1984, Current medical research and opinion.
[69] D. Meldrum,et al. Effect of Clonidine on Hot Flashes in Postmenopausal Women , 1982, Obstetrics and gynecology.
[70] P. Lomax,et al. Association of Waking Episodes with Menopausal Hot Flushes , 1981, JAMA.
[71] G. Anderson,et al. The use of medroxyprogesterone acetate for relief of climacteric symptoms. , 1980, American journal of obstetrics and gynecology.
[72] W. Chesarek,et al. Postmenopausal hot flushes: a disorder of thermoregulation. , 1980, Maturitas.
[73] R. Lindsay,et al. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. , 1980, British medical journal.
[74] J. Patterson,et al. A STUDY OF THE EFFECTIVENESS OF PROPRANOLOL IN MENOPAUSAL HOT FLUSHES , 1978, British journal of obstetrics and gynaecology.
[75] Gambrell Rd,et al. Use of medroxyprogesterone acetate to prevent menopausal symptoms. , 1975 .
[76] T. Lebherz,et al. Nonhormonal Treatment of the Menopausal Syndrome: A Double-Blind Evaluation of an Autonomic System Stabilizer , 1969, Obstetrics and gynecology.
[77] William Francis Ganong,et al. Review of Medical Physiology , 1969 .